How Sino Biological-Developed Anti-Linker Antibodies Simplify CAR-T Detection and Development
Sinoâs anti-Whitlow 218 linker antibody offers a universal way to measure CAR expression across different constructs wit...
Twist Bioscience Expands Synthetic DNA Capabilities and Enables Faster Discovery across Multiple Fields
The faster our customers succeed, the better for the world, and Twist Bioscience is uniquely positioned to help accelerate these efforts. We have created a revolutionary silicon platform that offers precision at a scale unavailable anywhere else.
Switzerlandâs Roche Strikes $3.5 Billion Deal to Acquire US Drugmaker 89bio
Roche expands its pipeline in cardiovascular, renal, and metabolic diseases through a $3.5 billion acquisition, aiming t...
Investment-Starved Biotech Sector in US Awaits Major Funding Boost to Help It Regain Global Edge
While this sector has been attracting early-stage funding, private investment in biotech and biopharma has been down in...
NewLimit Secures $130M Series B to Push Boundaries of Anti-Aging Drug Development
The biotech startup co-founded by Coinbaseâs Brian Armstrong is using AI to accelerate epigenetic reprogramming with an...
